Recently, the first example of a human mutation in the gene encoding the de
smosomal plaque protein, desmoplakin, has been described in a patient with
autosomal dominant striate palmoplantar keratoderma. We now report a furthe
r case of desmoplakin mutation in a proband with striate palmoplantar kerat
oderma that also results in a null allele and haploinsufficiency. The mutat
ion was a heterozygous G>A transition at the donor +1 site of intron 7 of t
he desmoplakin gene (939+1 G>A; Genbank M77830). The aberrant splicing lead
s to retention of the entire intron 7, which contains a premature terminati
on codon within the N-terminal domain of the peptide. Because the mutant nu
ll allele could not be identified on cDNA sequencing, we determined by poly
merase chain reaction the exon-intron organization of the desmoplakin gene
to facilitate analysis of genomic DNA. The gene spans approximately 45 kb o
f chromosome 6 and comprises 24 exons ranging in size from 51 bp to 3922 bp
, We have also characterized fully the 3'UTR of the desmoplakin cDNA. This
study demonstrates the relevance of haploinsufficiency for desmoplakin in t
he pathogenesis of this genodermatosis. Assessment of family members bearin
g the mutant allele also emphasizes the significance of an individual's age
and exposure to skin trauma in manifesting full phenotypic expression of t
he disorder.